Jayda Siggers

Dr. Jayda Siggers is a Senior Biologist/Evaluator in the Biotherapeutics Quality Divisions of the Centre for Blood, Blood Products and Biotherapeutics, within the Biologics and Radiopharmaceutical Drugs Directorate at Health Canada. Over the past ten years, she has led the quality review of pre- and post-market submissions for biologic therapies. Dr. Siggers holds an MSc in Toxicology from the University of Saskatchewan, a PhD in Immunology from the University of Copenhagen, and completed a postdoctoral fellowship in Biochemistry, Microbiology, and Immunology at the University of Ottawa. She actively contributes to advancing biologics regulation and global standards. Dr. Siggers is actively engaged in advancing regulatory science and global standards for biologics, representing Health Canada on the WHO guidance for the production and quality control of monoclonal antibodies, developing a PAHO training module on the evaluation of therapeutic antibodies, and co-chairing a PDA standard on analytical method transfer and comparability. Her policy work includes contributions to the new biologic drug regulations (Division 4) under the Food and Drugs Act, the revision of Health Canada’s biosimilars guidance, and participation as a member of the ICH M18 Expert Working Group. Outside of work, Jayda can often be found chasing her family up hills and down mountains on one of her bikes.